WHO ICTRP trial
Effect of zusanli injection of neostigmine on gastrointestinal function in…
ChiCTR1800017379 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800017379 |
|---|---|
| Public title | Effect of zusanli injection of neostigmine on gastrointestinal function in severe patients |
| Scientific title | Effect of zusanli injection of neostigmine on gastrointestinal function in severe patients |
| Primary sponsor | TaizhouTraditional Chinese Medicine Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Severe patients with gastrointestinal dysfunction |
| Interventions | A:blank;B:neostigmine was injected into zusanli;C:neostigmine injection of simin |
| Registration date | Jul 27, 2018 |
| Target size | A:83;B:83;C:83 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: